和铂医药-B(02142)11月7日斥资497.15万港元回购40万股
HBM HOLDINGSHBM HOLDINGS(HK:02142) 智通财经网·2025-11-07 13:02

Group 1 - The company, HAPO Pharmaceuticals-B (02142), announced a share buyback plan on November 7, 2025, involving an expenditure of HKD 4.9715 million to repurchase 400,000 shares [1] - The buyback price is set between HKD 11.98 and HKD 12.70 per share [1]